key: cord-0707862-63z95jxn
authors: Rosman, Lindsey; Mazzella, Anthony J; Gehi, Anil; Liu, Yutong; Li, Quefeng; Salmoirago‐Blotcher, Elena; Lampert, Rachel; Burg, Matthew M.
title: Immediate and Long‐term effects of the COVID‐19 pandemic and lockdown on physical activity in patients with implanted cardiac devices
date: 2021-11-15
journal: Pacing Clin Electrophysiol
DOI: 10.1111/pace.14409
sha: 25c8f55a1304e6af3251990edd491afcb0008833
doc_id: 707862
cord_uid: 63z95jxn

BACKGROUND: : Physical activity (PA) is an important determinant of cardiovascular health that may be affected the COVID‐19 pandemic. Therefore, we examined the immediate and long‐term effects of the pandemic and lockdown on PA in patients with established cardiovascular risk. METHODS: : Objectively‐measured daily PA data was obtained from cardiovascular implantable electronic devices (CIEDs) from 3,453 U.S patients (mean [SD] age, 72.65 [13.24] years; 42% women). Adjusted mixed‐effects models stratified by device type were used to compare daily PA from periods in 2020: pre‐lockdown (March 1 to 14), lockdown (March 15 to May 8), and the re‐opening phase of the pandemic (May 9 to December 31) versus 2019. Patient characteristics and events associated with inactivity during lockdown and the proportion of patients who returned to their 2019 PA‐level by the end of re‐opening phase (December 31, 2020) were examined. RESULTS: : Daily PA was significantly lower during the lockdown compared to the same period in 2019 (‐15%; p<0.0001), especially for pacemaker patients, adults aged <65, and patients more active prior to lockdown. Non‐COVID hospitalization and ICD shock were similarly associated with low PA during lockdown (p = 0.0001). In the re‐opening phase of the pandemic, PA remained 14.4% lower in the overall sample and only 23% of patients returned to their 2019 PA level by the end of follow‐up. CONCLUSIONS: : In this large cohort of patients with CIEDs, PA was markedly lower during the lockdown and remained lower for months after restrictions were lifted. Strategies to maintain PA during a national emergency are urgently needed. This article is protected by copyright. All rights reserved

Physical activity (PA) is an important factor for prevention and management of cardiovascular disease (CVD) 1 that has been greatly affected by the outbreak of a novel coronavirus in 2019 (SARS-CoV-2) and public health strategies to reduce the global burden of COVID-19. Among the general population, preliminary data from a study of 185,000 U.S adults showed a 48% decrease in daily PA during a nationwide lockdown (March through April 2020). 2 Sedentary behaviors such as time spent using the computer, lying down, and watching television also increased substantially in the U.S and in other countries during mandatory lockdowns. 2, 3 These trends are concerning, as even relatively short periods of reduced PA (1-14 days) can promote metabolic, inflammatory and hemodynamic alterations that increase risk for cardiovascular morbidity, mortality, and arrhythmogenic complications in patients with underlying cardiac dysfunction. 1, 4 Longer durations of inactivity (≥ 4 weeks) have also been associated with decreased exercise tolerance, increased pulmonary congestion, and a higher risk of hospitalization in patients with heart failure. 5, 6 Considering that millions of adults with underlying CVD may self-isolate for a longer duration due to a heightened risk of morbidity and mortality from COVID-19, 7 it is paramount to identify patients who may benefit from close monitoring and referral to PA interventions to prevent clinical deterioration.

Accordingly, we sought to describe and quantify the effects of the COVID-19 pandemic and the statewide lockdown in North Carolina on daily PA in a large, wellcharacterized cohort of patients with implanted cardiac devices. Since longitudinal PA is automatically collected by implanted cardiac devices and is routinely integrated into electronic health records (EHR), these devices provide a unique opportunity for analysis of PA trends before, during, and after the lockdown in a population of patients with pre-existing CVD who are typically older with multiple comorbidities. We also examined patient This article is protected by copyright. All rights reserved . 5 characteristics and clinical events associated with inactivity during the lockdown and assessed the extent to which reductions in PA persisted after restrictions were lifted. Lastly, we identified subgroups of patients at risk for worse health outcomes due to prolonged inactivity during the COVID-19 pandemic.

To contain the spread of COVID-19, the Governor of North Carolina issued a series of executive orders beginning on March 15 , 2020 that strongly encouraged residents to stay home, and closed schools, restaurants, gyms, and other non-essential businesses. A statewide, stay-at-home order was issued on March 30, 2020 until April 23, 2020, and later extended until May 8, 2020. On May 9 th non-essential businesses, public parks, and eventually restaurants and some schools re-opened at a reduced capacity.

We examined daily PA from January 1, 2019 to December 31, 2020. Pre-pandemic data from 2019 were used to establish long-term PA trends and control for seasonal variation in activity. 8 The average number of minutes of PA per day from March 1, 2020 to March 14,  2020 were used to calculate a pre-lockdown level of PA for each patient, allowing us to control for baseline PA in our analysis. We defined the COVID-19 lockdown period as March 15, 2020 to May 8, 2020 and the re-opening phase of the pandemic as May 9, 2020 through December 31, 2020 (end of study follow-up). Daily PA during the COVID-19

lockdown and re-opening phase of the pandemic were compared with data from the corresponding periods in 2019. This study design and analytic approach has been used previously to assess potential adverse health impacts of the COVID-19 pandemic. 9 The institutional review board at the University of North Carolina at Chapel Hill

School of Medicine approved the study and waiver of informed consent. The manufacturers This article is protected by copyright. All rights reserved. 6

of devices used in this study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The data that support the findings of this study are available from the corresponding author upon reasonable request.

The study cohort was derived from patients enrolled in the UNC Cardiovascular Figure 1 shows the geographic distribution of participating hospitals and patients (using zip code of residence Daily PA data were obtained from the accelerometer embedded in the CIED generator. The process of PA data collection by CIED accelerometer and a summary of validation studies are available in a recently published review. 10 Briefly, as the patient moves or accelerates, internal sensors detect changes in the frequency and amplitude of body motion, generating an electrical signal that is proportional to patient movement. 11 Patient acceleration that meets or exceeds a pre-programmed threshold is considered an active minute and the total minutes of PA per day are automatically stored in device memory. PA is recorded similarly by Medtronic and Boston Scientific devices and would be considered light-intensity PA that is equivalent to walking at a slow pace (details provided in the Data Supplement). 12 As in previous studies, 13 PA data from the first 30 days post-implant were excluded from analysis to account for procedural recovery. In addition, data on all episodes of ICD shock were obtained from the registry because prior studies have shown a significant reduction in PA after ICD shock. 14 Electrograms for all arrhythmia episodes treated by ICD shock were adjudicated by a board-certified electrophysiologist in a blinded manner.

Sociodemographic information, clinical history, medications, and hospitalizations were abstracted from outpatient and inpatient EHR notes using automated computer algorithms and standard methodology. 15 

In the overall study cohort (Figure 2 ), we observed significantly lower PA during the lockdown compared to the same period in 2019 (15% lower overall PA; p<0.0001). Patterns were generally consistent when stratified by device type ( In addition, Figure 2 shows the potential impact of daily case rates of COVID-19 in North

Carolina on overall PA trends. The data show an inverse association between new cases of COVID-19 in North Carolina and daily PA, suggesting that changes in PA during the reopening phase of the pandemic were often affected by fluctuations in COVID-19 infections.

Until now, information on the secondary health impacts of the pandemic has been limited, especially in medically vulnerable populations, such as those with underlying CVD, who are more susceptible to acute changes in health status. The principal findings from this study include the following: 1) daily PA was significantly lower in the overall cohort (15%) inappropriate shocks. This finding is consistent with data from a prior study, 14 and suggests that the experience of ICD shock -not the underlying arrhythmia -triggered the behavioral response (i.e., immediate reduction in PA). These results suggest that there may be opportunities to leverage PA data obtained from CIEDs to proactively identify patients at risk for adverse outcomes due to prolonged inactivity and link them to interventions that can facilitate patients' recovery, and return to activity following critical events, such as a global pandemic, lockdown, ICD shock, or even a prolonged period of time spent at home. 

PA is an effective preventive measure that can reduce CVD progression and mortality. 1 Thus, early and ongoing education about the health benefits of PA and the risks of prolonged inactivity is essential to optimize CVD self-management. 26 

This study has some limitations. First, although the UNC CDSR captures data from multiple centers and hospitals located throughout North Carolina, this is a study of patients from a single healthcare system. Second, information on some clinical parameters were not available for this study including NYHA (New York Heart Association) heart failure classification, ejection fraction, and data on lifestyle factors (e.g., adherence to medical therapies, sleep and diet). 19 This is a common limitation of registry-based studies that utilize administrative data. 9 Information on device indication was also not available and PA patterns may differ according to underlying cardiovascular etiology. 1 However, in prior studies, PA measured by CIEDs has not been found to differ among primary and secondary prevention patients after correcting for device type. 14 Thus, we stratified our analyses by device type.

Third, CIED sensors are highly sensitive to the onset of PA but they are less sensitive to short bursts of movement or vibrations, 30 and they are not able to determine the type or intensity of This article is protected by copyright. All rights reserved. 16 PA performed (i.e., light, moderate vigorous), 10 and the data cannot be used to compute metabolic equivalent tasks (METs). 31 Thus, data from CIEDs may not generalize to data obtained from other wearable PA devices. Developing CIED-specific PA thresholds will enhance the utility of these data. Finally, we did not have sufficient statistical power to investigate whether reductions in PA during the pandemic were associated with subsequent increases in hospitalizations or deaths. Larger studies are required to ascertain the association between reduced PA during the pandemic and health outcomes.

In 

Promoting Physical Activity and Exercise: JACC Health Promotion Series

Evidation Health I. COVID-19 pulse: delivering regular insights on the pandemic from a 150,000+ person connected cohort

Worldwide Effect of COVID-19 on Physical Activity: A Descriptive Study

Short-term physical inactivity impairs vascular function

Exercise and heart failure: A statement from the American Heart Association Committee on exercise, rehabilitation, and prevention

Association of Implantable Device Measured Physical Activity With Hospitalization for Heart Failure

The impact of the COVID-19 pandemic on the care and management of patients with acute cardiovascular disease: a systematic review

Seasonal variation in physical activity in patients with heart failure

Incidence of New-Onset and Worsening Heart Failure Before and After the COVID-19 Epidemic Lockdown in Denmark: A Nationwide Cohort Study

Measuring Physical Activity With Implanted Cardiac Devices: A Systematic Review

Device sensing: sensors and algorithms for pacemakers and implantable cardioverter defibrillators

The Physical Activity Guidelines for Americans

Patient Activity and Survival Following Implantable Cardioverter-Defibrillator Implantation: The ALTITUDE Activity Study

Defibrillator Shocks and their Impact on Objective and Subjective Patient Outcomes: Results from the PainFree SST Clinical Trial

Linking Data for Health Services Research: A Framework and Instructional Guide

Consequences for the Elderly After COVID-19 Isolation: FEaR (Frail Elderly amid Restrictions)

Medications ACE-inhibitor or ARB

Medications ACE-inhibitor or ARB

This article is protected by copyright. All rights reserved. 24Notes and definitions: ICD = implantable cardioverter defibrillator; TIA = transient ischemic attack; COPD = chronic obstructive pulmonary disease; ACE = angiotensin converting enzyme; ARB = angiotensin receptor blocker. ‡ Data are presented as mean ± standard deviation (SD). † Antidepressant medications include selective serotonin reuptake inhibitors/serotonin and norepinephrine reuptake inhibitors. § A composite variable was created for any prior diagnoses of anxiety disorders: generalized anxiety disorder, post-traumatic stress disorder, acute stress disorder and panic disorder.This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1111/pace.14409.This article is protected by copyright. All rights reserved.

This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1111/pace.14409.